EUVIMEDEUVIMED entdecken
Crossref

AI‐Enhanced Continued Process Verification for Ultrafiltration/Diafiltration

Naveen G Jesubalan, Nikita Saxena, Vinesh Balakrishnan Yezhuvath, Navnath Deore, Anurag S Rathore iD

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Naveen G Jesubalan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Interdisciplinary Research (SIRe), Indian Institute of Technology Delhi, Hauz Khas, India. Hauptthemen laut MEDLINE: Artificial Intelligence, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: The article received funding support from Tata Consultancy Services and the Department of Biotechnology, Ministry of Science and Technology through the Center….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The guidelines from the Food and Drug Administration (FDA) and the European Union Good Manufacturing Practice (EU GMP) Annex 15 necessitate biopharmaceutical manufacturers to uphold continuous control of their processes throughout the product lifecycle, thereby ensuring consistent strength, quality, and purity of the final drug product. As a result, there is enormous interest in continued process verification (CPV) in the biopharmaceutical industry. Typical manufacturing processes generate significant process and analytical data for every manufactured batch. The industry has accepted that manual data collection and statistical trending are labor‐intensive and error‐prone. In this study, an attempt has been made to streamline CPV for the ultrafiltration–diafiltration unit operation. It entails numerous tasks, including data acquisition using sensors, predictive machine learning models, statistical trending against control limits, process capability assessment (Cpk and Ppk) at defined intervals, fault detection, and a robust process control strategy. We hope the proposed framework will help the biopharmaceutical industry implement CPV and move closer to adopting Industry 4.0.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBiological ProductsUltrafiltrationMachine LearningDrug Industry

Stichwörter der Autor:innen

continued process verification (CPV)control chartsmachine learningmonoclonal antibodyultrafiltration diafiltration (UF DF)

Substanzen

Biological Products

Autor:innen und Institutionen

  • School of Interdisciplinary Research (SIRe), Indian Institute of Technology Delhi, Hauz Khas, India.
  • Department of Chemical Engineering, Indian Institute of Technology Delhi, Hauz Khas, India.
  • TCS Research, Tata Consultancy Services Limited, Pune, India.

ORCID-Profile: Anurag S Rathore

Förderung

  • The article received funding support from Tata Consultancy Services and the Department of Biotechnology, Ministry of Science and Technology through the Center…

Zitieren

APA

Jesubalan, N. G., Saxena, N., Yezhuvath, V. B., Deore, N., & Rathore, A. S. (2026). AI‐Enhanced Continued Process Verification for Ultrafiltration/Diafiltration. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70075

Vancouver

Jesubalan NG, Saxena N, Yezhuvath VB, Deore N, Rathore AS. AI‐Enhanced Continued Process Verification for Ultrafiltration/Diafiltration. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70075

BibTeX
@article{Jesubalan2026,
  author = {Jesubalan, Naveen G and Saxena, Nikita and Yezhuvath, Vinesh Balakrishnan and Deore, Navnath and Rathore, Anurag S},
  title = {AI‐Enhanced Continued Process Verification for Ultrafiltration/Diafiltration},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70075}
}
Kostenlos starten →